Patient safety is essential for providing high‑quality basic health services.
EXAMINATIONS
PER YEAR
EXPERTS
ANDSCIENTISTS
ANNUAL PRODUCTION
OF RADIOPHARMACEUTICALS
YEARS
OF EXPERIENCE
Vyšetrení ročne
odborníkov a vedcov
ročná produkcia rádiofarmák
rokov skúseností
Reporting adverse drug effects
BIONT’s own product – biontFDG radiopharmaceutical – is already registered in six EU countries. Since 2012, it has been manufactured under license by the company Eczacibasi-Monrol in Romania and is currently building new factories in Bulgaria and Poland. In addition to the standard PET/CT examination using FDG, BIONT provides examination using 11C-Methionine and expands its production to include other PET radiopharmaceuticals. BIONT is also a contract manufacturer of FDG for Radiomedic (Czech Republic) and DSD Pharma (Austria).
© 2005 – 2024 BIONT, a. s. | Last update: 21.10.2024 | GDPR-related data gdpr@biont.sk